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1. Introduction 
Successful application of liposomes as drug carriers 
[ 1,2] requires control of the extent of drug retention 
by its carrier in the biological milieu. Thus, although 
in many instances drugs must be transported quantita- 
tively to where they are needed,in others their gradual 
release may be preferable, especially when membrane 
barriers prevent liposomes from reaching target sites 
[ 11. However, work on the in vivo fate of a number 
of liposome-entrapped drugs [2,3] indicates that, 
after intravenous injection, there is an almost imme- 
diate release of drug in the blood circulation, The rate 
at which this occurs is much higher than that expected 
from solute diffusion through intact bilayers [4,5] 
and it has been attributed, at least in part, to the loss 
of the structural integrity of liposomes as a result of 
phospholipid removal by high density lipoproteins 
[6-81. We have shown [4,.5,9] that in the blood of 
injected animals or in vitro in the presence of whole 
blood, plasma or serum, stability (in terms of bilayer 
permeability to solutes) of small multilamellar [4,9] 
or small unilamellar [S] liposomes can be controlled 
by adjusting their cholesterol content. Greatest 
liposomal stability with total retention of entrapped 
solutes both in vivo and in vitro was achieved by using 
small unilamellar liposomes composed of equimolar 
amounts of phospholipid and cholesterol [.5]. Here 
we show that cholesterol stabilises liposomes in the 
presence of serum by reducing the loss of their phos- 
pholipid component to high density lipoproteins. 
2. Materials and methods 
Sources and grades of egg phosphatidylcholine, 
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cholesterol, [ 1 -14C] cholesteryl oleate (34 mCi/mmol), 
6-carboxyfluorescein and Sepharose CL-6B have been 
described [4,5]. Egg [3H] phosphatidylcholine 
(1.05 mCi/pmol) was radiolabelled by catalytic 
hydrogenation [lo] of the fatty acid ester groups. 
Ultrogel AcA 34, bead size (swollen) 60-140 pm, 
was purchased from LKB, France. All other reagents 
used were of analytical grade. 
Small unilamellar liposomes containing 6-carboxy- 
fluorescein were prepared [S] from CHC13 solutions 
of 40 pmol egg phosphatidylcholine, tracers of the 
radiolabelled egg phosphatidylcholine (2.7 FCi) and 
cholesteryl oleate (0.08 yCi) and, when appropriate, 
20 or 40pmol cholesterol. The solvent was evaporated 
under a stream of O*-free N2 and the dried lipids were 
subsequently disrupted with 2 ml 0.1 M sodium phos- 
phate buffer supplemented with 0.8% NaCl and 0.2% 
KC1 (phosphate buffer, pH 7.4) and containing 
0.25 M 6-carboxyfluorescein. The suspension was 
sonicated for 10 min (1 min sonication with 30 s 
cooling periods) at 4’C and then centrifuged at 
100 000 X g for 60 min [5]. Separation of 6-carboxy- 
fluorescein containing small unilamellar liposomes in 
the supernatant from the untrapped dye was carried 
out on a Sepharose CL-6B column (1 X 25 cm) 
equilibrated with phosphate buffer, the liposomes 
were then dialysed against the same buffer until their 
use, at most within 24 h following the gel filtration 
step. The diameter of such liposomes, measured by 
electron microscopy, was 30-60 nm [5]. 6-carboxy- 
fluorescein in appropriately diluted liposomal samples 
was measured in the absence (free dye) and presence 
(total dye) of Triton X-100 (1% final cont.) on a 
Perkin-Elmer 204A fluorimeter using excitation and 
emission wavelengths of 490 and 520 nm, respectively. 
As little as 4 ng 6-carboxyfluorescein/ml could be 
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measured accurately. The % latent 6-carboxyfluores- 
cein in the liposomal preparation was estimated from 
1 OO(Dyet -Dyef)/Dyet , where t and f denote total 
and free dye, respectively. 
Fresh human serum (1 .O ml) obtained from healthy 
volunteers was incubated with 0.1 ml 6-carboxy- 
fluorescein-containing doubly radiolabelled liposomes 
at 37°C for 30 min. On one occasion serum was 
heated at 55°C for 30 min to inactivate lecithir- 
cholesterol acyl transferase (LCAT) before mixing 
with liposomes. Subsequently, 0.50 ml mixture was 
passed at 20°C through an Ultrogel AcA 34 column 
(1 X 2.5 cm) equilibrated with phosphate buffer. The 
column was eluted with the same buffer at 0.4 ml/min 
flowrate and the I .O ml fractions obtained were anal- 
ysed for free, total and latent 6-carboxyfluorescein as 
above and protein by spectrophotometry at 280 nm. 
For the assay of 3H [ 1 l] and 14C [5] double isotope 
counting conditions were set: 14C was counted at 
90% efficiency with no crossover of 3H into the r4C 
channel; efficiency for 3H counting was 33% with 
55% crossover of 14C into the 3H channel. This was 
taken into consideration in estimating 3H radioactivity. 
In control experiments 1 .O ml serum mixed with 
0.1 ml phosphate buffer or 0.1 ml liposomes mixed 
with 1 .O ml phosphate buffer were treated similarly. 
In other experiments, following incubation of 2.6 ml 
human serum with 0.26 ml liposomes as above, the 
mixture was fractionated [ 121 by sequential density 
centrifugation to chylomicrons, very low density 
(VLDL), low density (LDL) and high density (HDL) 
lipoproteins using a 6,X 5 ml swingout rotor and a 
Superspeed 65 centrifuge. 3H and 14C radioactivities 
were measured in the fractions obtained. In one 
experiment individual lipoprotein fractions were 
passed through Ultrogel AcA 34 columns (1 X 25 cm). 
3. Results and discussion 
We have investigated the tentative suggestion [4,5] 
that cholesterol stabilises small unilamellar liposomes 
in the presence of serum by interfering with phospho- 
lipid loss to HDL. Changes in the structural integrity 
of liposomes were monitored by following the fate of 
two radiolabels ( [3H]phosphatidylcholine and [ 14C]- 
cholesteryl oleate) incorporated into the lipid phase 
and of 6-carboxyfluorescein entrapped in the aqueous 
phase at a concentration (0.25 M) which quenches 
the dye fully. When liposomes become leaky because 
of changes in bilayer permeability to the solute, 
entrapped 6carboxyfluorescein escapes into the 
medium to attain a concentration which allows the 
dye to fluoresce [ 131. This offers a direct method for 
measuring changes in liposomal stability [4,5] and 
also the detection of intact (quenched dye-containing)- 
liposomes. 
After incubation of the cholesterol-free liposomes 
with serum and the subsequent fractionation of the 
latter through an Ultrogel AcA 34 column, only a 
small portion (7.3% of total recovered) of the lipo- 
somal6-carboxyfluorescein is eluted in a latent form 
(entrapped) with fractions 11-14 (fig.1). These frac- 
tions, obtained ahead of most serum proteins (fig.D), 
contain the eluate in which liposomes together with 
entrapped 6carboxyfluorescein and the two radio- 
labels are recovered quantitatively when chromato- 
graphed in the absence of serum (legend to fig.1). Most 
(87.1%) of the dye initially associated with liposomes 
is eluted in its free form with fractions 26-34. This 
massive release of 6carboxyfluorescein is paralleled 
by the loss of considerable proportions of the [3H] - 
phosphatidylcholine and [ 14C] cholesteryl oleate 
markers to the serum protein containing fractions 
with only 32.9% and 36.5%, respectively retained by 
liposomes in fractions 11-14 (fig.lA). Practically 
identical patterns of radioactivity (3H and r4C) elution 
were obtained when LCAT in the serum was inac- 
tivated before mixing with liposomes (not shown). 
Furthermore, when serum incubated with the choles- 
terol-free liposomes was subjected to sequential den- 
sity centrifugation (table l), most of the two radiolabels 
were found associated with the LDL(43.7% and 45.5%) 
and the HDL (43.9% and 36.0% for [ 3H] phosphatidyl- 
choline and [ 14C]cholesteryl oleate, respectively). A 
similar association of the two liposomal lipid markers 
with serum HDL has been already observed [6] associa- 
tion of liposomal phosphatidylcholine with HDL 
shown [7,8] to represent net transfer of lipid which 
incorporates itself into the HDL lipid coat [ 141. Phos- 
pholipid transfer also occurs when liposomes are incu- 
bated with purified HDL and apo HDL [8,15-171 
but not with purified LDL and VLDL [8]. Since LDL 
both coelutes (legend to fig.1) and cosediments upon 
ultracentrifugation [8] together with small unilamellar 
liposomes, it is very likely thatthe recovery of some 
of the 14C and 3H labels with the LDL fraction 
(table 1) merely reflects cosedimentation of the 
remainder of the liposomal entity and the lipoprotein. 
Incorporation of increasing amounts of cholesterol 
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Fig.1. Small unilamellar liposomes (2.0 omol phospholipid in 
0.1 ml) composed of egg phosphatidylcholine [(A) alone or 
(B) supplemented with 1 .O or (C) 2.0 pmol cholesterol], 
radiolabelled with [ l-14C]cholesteryl oleate and egg [‘HI- 
phosphatidylcholine and containing 6-carboxyfluorescein 
were incubated with 1 .O ml human serum at 37°C for 30 min 
(see section 2). Subsequently, 0.5 ml of each mixture 
(7.4-7.9 X lo3 dpm, “‘C; 2.5-2.7 X 10’ dpm, ‘H; 
8.2-32.0 Fg 6-carboxyfluorescein) was passed through an 
Ultrogel AcA 34 column. Fractions were analysed for 14C 
(solid line), ‘H (broken line) and 6-carboxyfluorescein 
(dotted line). Latency for 6carboxyfluorescein was 95-10170 
in fractions 1 l-l 4 (denoting intact liposomes) and nil in all 
other fractions. In one experiment serum alone was chroma- 
tographed as above and fractions were analysed for protein 
(D). All values are expressed as 70 of total radioactivity, dye 
and protein recovered. Recoveries were 966106% of the 
quantities applied. When 0.1 ml liposomes were incubated 
with 1 .O ml phosphate buffer (in the absence of serum) and 
0.5 mixture was then passed through the column, 95-104% 
of “‘C, ‘H and 6-carboxyfluorescein were recovered in frac- 
tions 11-14. LDL and HDL purified [ 121 from human serum 
and then passed through the column were recovered in bulk 
in fractions 11-14 and 15-24, respectively. 
(2.0 and 1 .O phospholipid:cholesterol molar ratio) 
into liposomes greatly diminished the release of 
entrapped 6-carboxyfluorescein in the presence of 
serum (fig.lB,C) and with a phospholipid:cholesterol 
molar ratio of 1 .O, 83.0% of the dye recovered in all 
fractions remained entrapped, presumably in intact 
liposomes (fig.1 C). Stabilisation in terms of solute 
Table 1 
Distribution of radioactivity in the lipoproteins of human serum incubated with 
liposomes radiolabelled with [ “YZ]cholesteryl oleate and egg [ ‘H]phosphatidylcholie 
Liposomes Molar ratio Chylomicrons VLDL LDL HDL 
PC/CHOL 
14C 3H 14C SD r4C 3H 14C SD 
PC 2.5 4.0 15.4 7.9 45.5 43.7 36.0 43.9 
PC, CHOL 2.0 3.3 3.0 12.8 4.5 46.2 60.2 37.1 31.0 
PC, CHOL 1.0 3.3 3.4 14.6 4.3 42.8 70.8 38.9 21.2 
Small unilamellar liposomes (5.2 hmol phospholipid in 0.26 ml) composed of egg 
phosphatidylcholine (PC) alone or supplemented with cholesterol (CHOL) and radio- 
labelled with [ lJ4C]cholesteryl oleate (6.4-8.2 X lo4 dpm) and [ 3H]phosphatidyl- 
choline (9.2 X lo’-1.3 X lo6 dpm) were incubated with 2.6 ml human serum which 
was subsequently fractionated into chylomicrons, very low density (VLDL), low 
density (LDL) and high density (HDL) lipoproteins (see section 2). Radioactivity 
valuesin the fractions are expressed as % of the total recovered. 3H and Y recoveries 
for the three liposomal preparations were 104-l 10% 
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release of liposomes with cholesterol was concurrent 
with their increased retention of phosphatidylcholine 
(up to 67.4%; fig.lB,C). This was consistent with the 
progressively increased recovery of the phospholipid 
in the LDL fraction (which coelutes and cosediments 
with liposomes, see above) and reduced association 
with the HDL fraction (down to 2 1.2% for liposomes 
with the higher cholesterol content). Interestingly, 
cholesterol incorporation into liposomes altered 
neither the pattern of cholesteryl oleate elution 
through the AcA 34 column (fig.1 B,C) nor its distribu- 
tion pattern upon ultracentrifugation (table 1). 
A possible mechanism by which phosphatidyl- 
choline from cholesterol-free small un~amellar lipo- 
somes is transferred to HDL in the presence of serum 
is that apoHDL loosely associated with the HDL par- 
ticles attaches itself to liposomes subsequent o colli- 
sion [8]. When a sufficient ratio of apoHDL to phos- 
pholipid is attained, the resulting apoHDL-liposome 
complex undergoes breakdown to smaller particles 
bearing a portion of the liposome-derived lipid and of 
a size similar to that of I-IDL [8]. The way by which 
cholesterol reduces such phospholipid transfer to HDL 
(fig.1, table 1) is not clear to us at present. It could 
be that packing of phospholipid molecules induced 
by the sterol [ 18,191 prevents the apoHDL from 
interacting with the liposomal surface. For instance, 
if such interaction entails insertion of hydrophobic 
regions of the protein into the bilayer, increased 
phospholipid packing could render this difficult. It is 
also possible that apoHDL and cholesterol-rich lipo- 
somes do form a complex but packing of phospholipid 
molecules by cholesterol or their binding to it [19] 
prevents them from being removed by the apoHDL. 
On the other hand, the failure of cholesterol to inter- 
fere with the loss of cholesteryl oleate HDL (table I) 
as it does with phosphatidylcholine (table 1) is com- 
patible with the notion [8] that cholesteryl oleate 
molecules tend to cluster in one region of the lipo- 
somal bilayer. In this way, the phospholipid-choles- 
teryl oleate complex becomes less stable than sur- 
rounding regions of phospholipid and, therefore, 
more susceptible to elimination by apoHDL [8]. It is 
of interest that loss of cholesteryl oleate from choles- 
terol-rich iiposomes to HDL as observed in the present 
studies, does not appear to occur in vivo. Thus, when 
serum from mice killed 3,30 and 60 min after intra- 
venous injection of [‘4C]cholesteryl oleate-labelled 
cholesterol-rich liposomes is ~hromatographed on an 
AcA 34 column, almost all radioactivity is retained 
by the carrier in fractions 1 l-l 4. In contrast) in 
similar in vivo work with cholesterol-free liposomes, 
the elution pattern of the cholesteryl oleate remains 
identical to that shown in fig.1 (unpublished). 
Although this discrepancy between the in vitro and 
in vivo behaviour of cholesteryl oleate is still under 
investigation, it would appear that for in vivo studies 
this lipid remains a valid marker for cholesterol-rich 
liposomes which it, apparently, follows to their desti- 
nation [5]. 
These results and [4,5,9] indicate that by adjusting 
the cholesterol content of liposomes, the permeability 
of their bilayers to solutes in vivo and in vitro can be 
influenced accordingly. This is achieved through the 
control which cholesterol exerts on both phospholipid 
loss to HDL and the ensuing destabilization of the 
liposomal structure. In addition to cholesterol [4,5, 
9,201 sphingomyelin may also contribute towards 
liposomal stability [ZO], although not necessarily by 
a similar mechanism. 
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